Oluyemi Okupe, the Chief Financial Officer of $HIMS, sold 9,067 shares of the company on 01-20-2026 for an estimated $275,113. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.0% of their shares of this class of stock. Following this trade, they now own 91,617 shares of this class of $HIMS stock.
$HIMS Insider Trading Activity
$HIMS insiders have traded $HIMS stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by insiders over the last 6 months:
- ANDREW DUDUM (Chief Executive Officer) has made 0 purchases and 17 sales selling 1,076,432 shares for an estimated $53,976,385.
- OLUYEMI OKUPE (Chief Financial Officer) has made 0 purchases and 12 sales selling 364,347 shares for an estimated $19,158,373.
- MICHAEL CHI (Chief Operating Officer) has made 0 purchases and 10 sales selling 77,349 shares for an estimated $4,288,956.
- PATRICK HARRISON CARROLL (Chief Medical Officer) has made 0 purchases and 3 sales selling 80,042 shares for an estimated $4,088,809.
- SOLEIL BOUGHTON (Chief Legal Officer) has made 0 purchases and 9 sales selling 23,531 shares for an estimated $1,166,808.
- IRENE BECKLUND (PAO) has made 0 purchases and 2 sales selling 16,821 shares for an estimated $733,472.
- DEBORAH M. AUTOR (Chief Policy Officer) sold 7,054 shares for an estimated $258,952
- GARCIA ANDREA G PEREZ sold 2,500 shares for an estimated $97,925
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HIMS Hedge Fund Activity
We have seen 295 institutional investors add shares of $HIMS stock to their portfolio, and 249 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 15,045,710 shares (+549.0%) to their portfolio in Q3 2025, for an estimated $853,392,671
- SRS INVESTMENT MANAGEMENT, LLC removed 4,000,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $226,880,000
- TIDAL INVESTMENTS LLC added 2,707,111 shares (+1779.6%) to their portfolio in Q3 2025, for an estimated $153,547,335
- FARALLON CAPITAL MANAGEMENT LLC added 2,533,271 shares (+30.8%) to their portfolio in Q3 2025, for an estimated $143,687,131
- PRICE T ROWE ASSOCIATES INC /MD/ added 2,504,252 shares (+444.1%) to their portfolio in Q3 2025, for an estimated $142,041,173
- RENAISSANCE TECHNOLOGIES LLC added 2,227,400 shares (+32.4%) to their portfolio in Q3 2025, for an estimated $126,338,128
- D. E. SHAW & CO., INC. removed 1,886,971 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $107,028,995
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HIMS Revenue
$HIMS had revenues of $599M in Q3 2025. This is an increase of 49.16% from the same period in the prior year.
You can track HIMS financials on Quiver Quantitative's HIMS stock page.
$HIMS Congressional Stock Trading
Members of Congress have traded $HIMS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $HIMS stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$HIMS Analyst Ratings
Wall Street analysts have issued reports on $HIMS in the last several months. We have seen 2 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 11/04/2025
- B of A Securities issued a "Underperform" rating on 11/04/2025
- Canaccord Genuity issued a "Buy" rating on 09/12/2025
To track analyst ratings and price targets for $HIMS, check out Quiver Quantitative's $HIMS forecast page.
$HIMS Price Targets
Multiple analysts have issued price targets for $HIMS recently. We have seen 6 analysts offer price targets for $HIMS in the last 6 months, with a median target of $42.5.
Here are some recent targets:
- Mark Mahaney from Evercore ISI Group set a target price of $33.0 on 01/12/2026
- Glen Santangelo from Barclays set a target price of $48.0 on 12/09/2025
- David Larsen from BTIG set a target price of $85.0 on 11/04/2025
- Allen Lutz from B of A Securities set a target price of $32.0 on 11/04/2025
- Maria Ripps from Canaccord Genuity set a target price of $68.0 on 09/12/2025
- Jailendra Singh from Truist Securities set a target price of $37.0 on 08/18/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
